Skip to main content
logo
Kiora Pharmaceuticals, Inc. (KPRX)
NASDAQ: KPRX · Real-Time Price · USD
2.560
+0.005 (0.20%)
Jul 31, 2026, 4:00 PM EDT - Market closed

Kiora Pharmaceuticals Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
--16.02---
Revenue Growth
------
Gross Profit
--16.02---
Operating Income
-13.01-12.834.51-12.59-12.31-14.24
Net Income
-11.06-10.843.59-13.04-13.58-13.77
Earnings Per Share
-2.71-2.640.87-24.25-166.95-514.08
EPS Growth
------

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
13.8717.0926.792.455.967.85
Total Debt
0.370.370.060.110.110.21
Net Cash (Debt)
13.516.7226.732.355.867.65
Net Cash Growth
-43.63%-37.46%1038.72%-59.93%-23.37%1150.70%
Net Cash Per Share
3.254.016.484.3672.00285.39

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-10.42-9.968.56-9.56-10.43-10.68
Capital Expenditures
-0.12-0.11-0.01---0.06
Free Cash Flow
-10.53-10.078.55-9.56-10.43-10.74
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
--100.00%---
Operating Margin
--28.15%---
Pretax Margin
--35.33%---
Profit Margin
--22.44%---
FCF Margin
--53.39%---

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingAug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
--3.79---
P/FCF Ratio
--1.16---
PS Ratio
--0.62---